TuisSRPT • NASDAQ
add
Sarepta Therapeutics Inc
Vorige sluiting
$17,91
Dagwisseling
$17,23 - $18,21
Jaarwisseling
$10,42 - $138,69
Markkapitalisasie
1,82 mjd USD
Gemiddelde volume
9,55 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 611,09 m | 68,38% |
Bedryfskoste | 138,56 m | -0,60% |
Netto inkomste | 196,89 m | 2 947,86% |
Netto winsgrens | 32,22 | 1 710,11% |
Wins per aandeel | 2,02 | 359,09% |
EBITDA | 126,42 m | 1 476,67% |
Effektiewe belastingkoers | -28,15% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 800,14 m | -45,21% |
Totale bates | 3,68 mjd | 7,46% |
Totale aanspreeklikheid | 2,32 mjd | -1,05% |
Totale ekwiteit | 1,36 mjd | — |
Uitstaande aandele | 97,71 m | — |
Prys om te bespreek | 1,29 | — |
Opbrengs op bates | 8,09% | — |
Opbrengs op kapitaal | 11,07% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 196,89 m | 2 947,86% |
Kontant van bedrywe | 261,34 m | 1 649,01% |
Kontant van beleggings | 32,21 m | 132,69% |
Kontant van finansiering | -23,82 m | -159,66% |
Netto kontantverandering | 269,73 m | 717,69% |
Beskikbare kontantvloei | 454,69 m | 1 643,42% |
Meer oor
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Gestig
1980
Webwerf
Werknemers
1 372
